GMP Certified Antibiotics Medicines Norfloxacin Capsule 100mg Shinepharm

• Customization: Available
• Application: Internal Medicine
• Usage Mode: For oral administration
• Suitable for: Elderly, Children, Adult
• State: Solid
• Shape: Capsules
• Type: Western Medicines
• Pharmaceutical Technology: Chemical Synthesis
• Function: Antibiotic
• Standard Available: Bp, Cp
• Delivery Time: 30~60 Days
• OEM/ODM: Support
• Transport Package: 12′s/Stripx25/Box, 40boxes/Carton
• Specification: 100mg 12x25Capsules
• Trademark: Shinepharm
• Origin: China
• HS Code: 3004909099
• Production Capacity: 1000000 Boxes/Month

Product Description

GMP Certified Antibiotics Medicines Norfloxacin Capsule 100mg Shinepharm

Indications

1.Urinary tract infections

2.Sexually transmitted diseases

3.Prostatitis

Dosage and Administration

Usage: Oral

Dosage:

Infection	Description	Unit Dose	Frequency	Duration	Daily Dose
Urinary tract infections Infection	Uncomplicated Urinary tract infections's (cystitis) due to E. coli, K.pneumoniae, or P. mirabilis	400 mg	q12h	3 days	800 mg
	Uncomplicated Urinary tract infections's due to other indicated organisms	400 mg	q12h	7-10 days	800 mg
	Complicated Urinary tract infections's	400 mg	q12h	10-21 days	800 mg
Sexually Transmitted Diseases	Uncomplicated Gonorrhea	800 mg	Single Dose	1 day	800 mg
Prostatitis	Acute or Chronic	400 mg	q12h	28 days	800 mg

PrecaUrinary tract infectionsons & Warning:

1.Tendinopathy and Tendon Rupture

2.Exacerbation of Myasthenia Gravis

3.Central Nervous System Effects/Disorders

4.Hypersensitivity Reactions

5.Peripheral Neuropathy

6.Syphilis Treatment

Contraindications:

Norfloxacin is contraindicated in persons with a history of hypersensitivity, tendinitis, or tendon rupture associated with the use of Norfloxacin or any member of the quinolone group of antimicrobial agents.

Adverse Reactions:

1.Gastrointestinal experiences including: abdominal pain, constipation, diarrhea, dyspepsia, flatulence, gross bleeding/perforation, heartburn, nausea, GI ulcers (gastric/duodenal) and vomiting.

2.Abnormal renal function, anemia, dizziness, edema, elevated liver enzymes, headaches, increased bleeding time, pruritus, rashes and tinnitus.

3.Additional adverse experiences reported occasionally include: Body as a Whole:fever, infection, sepsis , Cardiovascular System, Digestive System, Hemic and Lymphatic System, Metabolic and Nutritional, Nervous System, Respiratory System, Skin and Appendages, Special Senses, Urogenital System.

Drug interactions:

1.Quinolones, including Norfloxacin, have been shown in vitro to inhibit CYP1A2. Concomitant use with drugs metabolized by CYP1A2 (e.g.,, Clozapine, Ropinirole, Tacrine, Theophylline, Tizanidine) may result in increased substrate drug concentrations when given in usual doses.

2.Elevated serum levels of Cyclosporine have been reported with concomitant use of cyclosporine with Norfloxacin

3.Quinolones, including Norfloxacin, may enhance the effects of oral anticoagulants, including Warfarin or its derivatives or similar agents.

4.The concomitant administration of Quinolones including Norfloxacin with Glyburide (a sulfonylurea agent) has, on rare occasions, resulted in severe hypoglycemia.

5.Diminished urinary excretion of Norfloxacin has been reported during the concomitant administration of probenecid and Norfloxacin

Storage instructions:

Store at temperature not exceeding 30°C in a dry place. Protect from light.